FY2025 EPS Forecast for Travere Therapeutics Cut by Analyst
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Research analysts at Leerink Partnrs cut their FY2025 earnings per share estimates for Travere Therapeutics in a research report issued to clients and investors on Wednesday, June 11th. Leerink Partnrs analyst J. Schwartz now expects that the company will earn ($0.70) per share for the year, down […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Research analysts at Leerink Partnrs cut their FY2025 earnings per share estimates for Travere Therapeutics in a research report issued to clients and investors on Wednesday, June 11th. Leerink Partnrs analyst J. Schwartz now expects that the company will earn ($0.70) per share for the year, down […]
